Nuick IV 2500 contains Simoctocog alpha, a recombinant Factor VIII (rFVIII) concentrate indicated for hemophilia A. Developed by Fujimoto Pharmaceutical, this injectable drug (YJ code: 6343457D5024) is available as a 2,500 IU bottle with dissolving solution.
Nuick IV 2500
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).